Invitrogen™ Phospho-BRCA2 (Ser2095) Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5105585

Catalog No. PIPA5105585

Description

Antibody detects endogenous levels of BRCA2 only when phosphorylated at Ser2095.

Breast Cancer Type 2 susceptibility protein (BRCA2) is a tumor-suppressor protein reported to be involved in double-strand break repair, homologous recombination and S-phase checkpoint activation.

Specifications

• Antigen: Phospho-BRCA2 (Ser2095)
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: BRCA2
• Gene Alias: brca 2; BRCA1/BRCA2-containing complex, subunit 2; BRCA2; brca-2; BRCA2 DNA repair associated; BRCA2, DNA repair associated; BRCC2; breast and ovarian cancer susceptibility gene, early onset; breast and ovarian cancer susceptibility protein 2; breast cancer 2; breast cancer 2 tumor suppressor; breast cancer 2, early onset; breast cancer 2, mutation 1, University of Wisconsin-Madison; breast cancer susceptibility protein 2; breast cancer type 2 susceptibility protein; Breast cancer type 2 susceptibility protein homolog; BROVCA2; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Fanconi anemia group D1 protein; Fanconi anemia group D1 protein homolog; GLM3; mutant BRCA2; PNCA2; RAB163; RP11-298P3.4; XRCC11
• Host Species: Rabbit
• Purification Method: Sequential chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 12190, 360254, 675
• Content And Storage: -20°C
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
• Gene Accession No.: O35923, P51587, P97929
• Gene Symbols: BRCA2
• Immunogen: A synthesized peptide derived from human BRCA2(Accession P51587), corresponding to amino acid residues around phosphorylated Ser2095.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse, Rat
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov